Name | 3-(benzenesulfonyl)-1-(4-fluorophenyl)pyrrolo[3,2-b]quinoxalin-2-amine |
---|---|
Synonyms |
1-(4-Fluorophenyl)-3-(phenylsulfonyl)-1H-pyrrolo[2,3-b]quinoxalin-2-amine
1H-Pyrrolo[2,3-b]quinoxalin-2-amine, 1-(4-fluorophenyl)-3-(phenylsulfonyl)- CAY10602 |
Description | CAY10602 is a SIRT1 activator. |
---|---|
Related Catalog | |
Target |
SIRT1 |
In Vitro | Compounds (including CAY10602/compound 1) with SIRT1-activating properties have a significant effect on fat mobilization in differentiated adipocytes, and these compounds (including CAY10602) have antiobesity and/or antidiabetic properties. Compounds (including CAY10602) with SIRT1 activating potential exert strong suppression of TNF-α release at concentrations between 20 and 60 μM[1]. |
Cell Assay | 3T3L1 mouse fibroblasts and THP-1 leukemia cells are used and cultured following the supplier’s recommendations.THP-1 cells are treated first with representative compounds (including CAY10602/compound 1) followed by addition of lipopolysaccharide(LPS). THP-1 cells are plated at a density of 1.2×106 cells/mL in 0.4 mL (0.5×106 cells/treatment) in 24-well culture plates. The cells are preincubated with representative test compounds (including CAY10602) at 2 concentrations (20 or 60 μM) for 1 h under general tissue culture conditions[1]. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 596.2±50.0 °C at 760 mmHg |
Melting Point | 270 °C |
Molecular Formula | C22H15FN4O2S |
Molecular Weight | 418.444 |
Flash Point | 314.3±30.1 °C |
Exact Mass | 418.089966 |
PSA | 99.25000 |
LogP | 4.27 |
Vapour Pressure | 0.0±1.7 mmHg at 25°C |
Index of Refraction | 1.725 |